These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18612771)

  • 21. Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.
    Ramchandren S; Shy M; Feldman E; Carlos R; Siskind C
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):635-9. PubMed ID: 25157034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory manifestations in Charcot-Marie-Tooth disease.
    Gemignani F; Melli G; Alfieri S; Inglese C; Marbini A
    J Peripher Nerv Syst; 2004 Mar; 9(1):7-14. PubMed ID: 14871449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.
    Johnson NE; Heatwole C; Creigh P; McDermott MP; Dilek N; Hung M; Bounsanga J; Tang W; Shy ME; Herrmann DN
    Ann Neurol; 2018 Aug; 84(2):225-233. PubMed ID: 30014533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease.
    Niu HX; Wang RH; Xu HL; Song B; Yang J; Shi CH; Li YS; Zhang BQ; Wang SP; Yong Q; Wang YY; Xu YM
    Chin Med J (Engl); 2017 Aug; 130(15):1773-1778. PubMed ID: 28748848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial issues that face patients with Charcot-Marie-Tooth disease: the role of genetic counseling.
    Arnold A; McEntagart M; Younger DS
    J Genet Couns; 2005 Aug; 14(4):307-18. PubMed ID: 16047093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical spectrum and gender differences in a large cohort of Charcot-Marie-Tooth type 1A patients.
    Colomban C; Micallef J; Lefebvre MN; Dubourg O; Gonnaud PM; Stojkovic T; Jouve E; Blin O; Pouget J; Attarian S
    J Neurol Sci; 2014 Jan; 336(1-2):155-60. PubMed ID: 24246498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, neurophysiological and morphological study of dominant intermediate Charcot-Marie-Tooth type C neuropathy.
    Thomas FP; Guergueltcheva V; Gondim FA; Tournev I; Rao CV; Ishpekova B; Kinsella LJ; Pan Y; Geller TJ; Litvinenko I; De Jonghe P; Scherer SS; Jordanova A
    J Neurol; 2016 Mar; 263(3):467-76. PubMed ID: 26725087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ultrasound diagnosis of Charcot-Marie-Tooth disease].
    Noto Y
    Brain Nerve; 2014 Mar; 66(3):237-46. PubMed ID: 24607948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathic pain in patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Peric S; Basta I; Bozovic I; Kacar A; Marjanovic A; Ivanovic V; Brankovic M; Jankovic M; Novakovic I; Rakocevic Stojanovic V
    Neurol Sci; 2020 Mar; 41(3):625-630. PubMed ID: 31729581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tinetti and Berg balance scales correlate with disability in hereditary peripheral neuropathies: a preliminary study.
    Monti Bragadin M; Francini L; Bellone E; Grandis M; Reni L; Canneva S; Gemelli C; Ursino G; Maggi G; Mori L; Schenone A
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):423-7. PubMed ID: 25491315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in children with Charcot-Marie-Tooth disease.
    Burns J; Ryan MM; Ouvrier RA
    J Child Neurol; 2010 Mar; 25(3):343-7. PubMed ID: 19713553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entities.
    Loprest LJ; Pericak-Vance MA; Stajich J; Gaskell PC; Lucas AM; Lennon F; Yamaoka LH; Roses AD; Vance JM
    Neurology; 1992 Mar; 42(3 Pt 1):597-601. PubMed ID: 1549221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
    Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
    Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charcot-Marie-Tooth neuropathies: diagnosis and management.
    Jani-Acsadi A; Krajewski K; Shy ME
    Semin Neurol; 2008 Apr; 28(2):185-94. PubMed ID: 18351520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study.
    Pazzaglia C; Padua L; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Coraci D; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Neuromuscul Disord; 2019 Apr; 29(4):310-316. PubMed ID: 30926199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
    Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS
    Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.